paper aeroplanes illustrating the rise of biosimilars

Rise of the biosimilars

2018 was a significant year for biosimilars. October’s patent expiry of adalimumab, the world’s top selling prescription medicine, saw a raft of biosimilars launch,...
IV drip in a hospital setting. PPRS evolution

PPRS evolution and what does it mean for pharma?

How has the Pharmaceutical Price Regulation Scheme (PPRS) evolved since its inception in the 1950s, and what does its latest iteration mean for pharma? Price...
Woman walking up stairs. political response to the NHS 10 year plan

Politics and the NHS Long Term Plan

Claudia Rubin looks at the immediate political response to the NHS 10 Year Plan which launched in January. Politics always moves at an incredible pace as...
birds eye view of people. The future of cancer

What is the future of cancer?

4 February is World Cancer Day. It’s a commonly discussed disease with well-publicised media campaigns around causes and symptoms, but it still affects more...

How to engage payers in the NHS

How well pharma companies engage with payers within a morphing NHS landscape will determine whether brands succeed or fail. 2019 promises to be a year...
Man looking at sign showing cross roads for NHS commissioning

Is pharma prepared for future NHS commissioning?

What’s the future for NHS commissioning and is pharma prepared? The NHS has had commissioning since 1991 but it has definitely failed to thrive and,...
Waiting room graphic showing patient engagement

The importance of patient engagement

The trend for true patient engagement can only be good news for pharma and for patient outcomes. It is notoriously difficult to predict how patient...
expanding access to medicines

Sharing experience of expanding access to medicines

2018 was a challenging year for pharma companies. While our industry continues to discover and develop treatments that improve lives throughout the world, trust...
People standing demonstrating NHS leadership gender gap

Closing the NHS leadership gender gap

  From patient to pharma, everyone involved in the health service stands to benefit from closing the NHS leadership gender gap – and there...
women climbing ladders gender diversity in pharma

Tackling gender diversity in pharma leadership

When it comes to gender diversity in pharma leadership, research has found that the pharmaceutical industry is lagging far behind. What’s being done to...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...